ALGN stock stays on investors' radar, courtesy of its strong Invisalign potential and success with iTero.
ALGN is facing a decline in Invisalign ASPs for comprehensive treatment options. This results in a decline in the company's revenues.
Investors need to pay close attention to Align Technology (ALGN) stock based on the movements in the options market lately.
Align Technology (ALGN) reported earnings 30 days ago. What's next for the stock?
Align Technology achieves a CE mark for the Invisalign Palatal Expander System.
Align Technology unveils Invisalign Smile Architect software with Multiple Treatment Plans for providing customised treatment.
Align Technology reported mixed Q3 earnings, with a beat on EPS at $2.35 but a slight miss on revenue at $977.87M. Despite challenges in the U.S. market, growth in Asia Pacific, EMEA, and Latin America, and increased Clear Aligner volume, show resilience. Align's growth drivers include product enhancements, infrastructure investments, and partnerships, with expected revenue growth of 5.29%-7.53% year-over-year from Q4 2024 to Q4 2026.
Align Technology reports third-quarter 2024 revenue growth. This can be mostly attributed to a robust performance by the Imaging Systems & CAD/CAM Services business segment.
Align Technology, Inc. (NASDAQ:ALGN ) Q3 2024 Earnings Conference Call October 23, 2024 4:30 PM ET Company Participants Shirley Stacy - VP, Corporate Communications & IR Joe Hogan - President & Chief Executive Officer John Morici - Chief Financial Officer Conference Call Participants Brandon Vazquez - William Blair Jon Block - Stifel Elizabeth Anderson - Evercore ISI Jason Bednar - Piper Sandler David Saxon - Needham & Company Jeff Johnson - Baird Kevin Caliendo - UBS Michael Cherny - Leerink Partners Erin Wright - Morgan Stanley Mike Ryskin - Bank of America Operator Greetings. Welcome to the Align Third Quarter 2024 Earnings Call.
Although the revenue and EPS for Align Technology (ALGN) give a sense of how its business performed in the quarter ended September 2024, it might be worth considering how some key metrics compare with Wall Street estimates and the year-ago numbers.
Align Technology (ALGN) came out with quarterly earnings of $2.35 per share, beating the Zacks Consensus Estimate of $2.31 per share. This compares to earnings of $2.14 per share a year ago.
Align Technology missed Wall Street estimates for third-quarter revenue on Wednesday, on lower-than-expected demand for its clear teeth aligners among younger patients.